Pujari Rohini Revansiddappa, Bandawane Deepti Dinesh
Modern College of Pharmacy (for Ladies), Department of Pharmacology, Maharashtra, India
Modern College of Pharmacy, Department of Pharmacology, Maharashtra, India
Turk J Pharm Sci. 2021 Jun 18;18(3):332-338. doi: 10.4274/tjps.galenos.2020.95870.
5-Fluorouracil (5-FU) is a very potent and effective antineoplastic drug that has been widely used for the management of various types of cancer. However, the clinical use of 5-FU is often associated with severe toxicities including hepatotoxicity, which limit its therapeutic use as a potent anticancer agent. The present study aimed to evaluate the hepatoprotective activity of a plant phenolic acid, gentisic acid (GA) (2,5-dihyroxybenzoic acid), against hepatotoxicity induced by 5-FU administration in Wistar rats.
The rats were randomly divided into six groups, with six rats per group. Among these, group I and II served as normal control and 5-FU control groups, respectively. The rats in these groups received distilled water (1 mL/kg) for 14 days by oral route. Groups III, IV, V, and VI served as test groups and received GA at doses of 3, 10, 30, and 100 mg/kg body weight, respectively, via oral route for 14 days. From Day 9 onwards, all the groups, except group I, received intraperitoneal dose of 5-FU (20 mg/kg body weight) for five days up to day 14. At the end of the study, the rats were sacrificed, blood was withdrawn for biochemical estimations, and hepatic tissues were excised for histopathological evaluations.
Administration of 5-FU at a dose of 20 mg/kg body weight resulted in a significant increase in the serum levels of hepatic biomarkers, including aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, direct bilirubin, and total bilirubin. In comparison to these, 5-FU treatment resulted in a reduction in total protein content (TPC). This was accompanied by significant histopathological changes in the hepatic tissues of the rats, indicating severe hepatotoxicity. Pre- and co-administration of GA with 5-FU at doses of 30 and 100 mg/kg body weight for 14 days resulted in a dose-dependent amelioration of the 5-FU induced alterations in the biochemical and histopathological parameters.
The results of the study highlighted the potential of GA as a hepatoprotective agent for the prevention of 5-FU-induced hepatotoxicity.
5-氟尿嘧啶(5-FU)是一种非常强效且有效的抗肿瘤药物,已被广泛用于治疗各种类型的癌症。然而,5-FU的临床应用常常伴随着严重的毒性,包括肝毒性,这限制了其作为强效抗癌剂的治疗用途。本研究旨在评估一种植物酚酸龙胆酸(GA)(2,5-二羟基苯甲酸)对Wistar大鼠5-FU给药诱导的肝毒性的肝保护活性。
将大鼠随机分为六组,每组六只。其中,第一组和第二组分别作为正常对照组和5-FU对照组。这些组的大鼠通过口服途径接受蒸馏水(1 mL/kg),持续14天。第三组、第四组、第五组和第六组作为试验组,分别通过口服途径接受剂量为3、10、30和100 mg/kg体重的GA,持续14天。从第9天起,除第一组外,所有组在第14天之前连续五天腹腔注射剂量为20 mg/kg体重的5-FU。在研究结束时,处死大鼠,采集血液进行生化评估,并切除肝脏组织进行组织病理学评估。
以20 mg/kg体重的剂量给予5-FU导致血清肝生物标志物水平显著升高,包括天冬氨酸转氨酶、丙氨酸转氨酶、碱性磷酸酶、直接胆红素和总胆红素。与这些指标相比,5-FU治疗导致总蛋白含量(TPC)降低。这伴随着大鼠肝脏组织显著的组织病理学变化,表明严重的肝毒性。以30和100 mg/kg体重的剂量在5-FU给药前和给药期间联合给予GA 14天,导致5-FU诱导的生化和组织病理学参数改变呈剂量依赖性改善。
该研究结果突出了GA作为预防5-FU诱导的肝毒性的肝保护剂的潜力。